AIDS
Medically Reviewed by Dr. M. Salar Raza | Official SCFHS 2026 Blueprint
Clinical Pathway
AIDS (Acquired Immunodeficiency Syndrome) is the final, most severe stage of HIV infection, characterized by a profoundly compromised immune system that makes individuals highly susceptible to opportunistic infections and certain cancers. It is diagnosed when the CD4+ T-cell count drops below 200 cells/mm³ or when specific AIDS-defining opportunistic illnesses develop. The cornerstone of AIDS treatment is highly active antiretroviral therapy (HAART), a combination of drugs that suppress HIV replication, preserve immune function, and prevent further progression. HAART significantly reduces viral load, increases CD4+ T-cell counts, and improves overall health. Treatment also includes prophylactic antibiotics to prevent opportunistic infections and specific therapies for any active infections or cancers. Symptoms of AIDS are primarily due to the opportunistic infections and cancers that take advantage of the severely weakened immune system. Common manifestations include persistent fever, chronic diarrhea, significant unintentional weight loss, night sweats, fatigue, swollen lymph nodes, and recurrent severe infections like Pneumocystis pneumonia, Kaposi's sarcoma, and toxoplasmosis. Neurological complications such as AIDS dementia complex can also occur.
Clinical Reasoning
AIDS develops as a direct consequence of untreated or late-stage Human Immunodeficiency Virus (HIV) infection. HIV primarily targets and progressively destroys CD4+ T-lymphocytes, which are critical for coordinating the immune response. This progressive depletion leads to a severe immunodeficiency, rendering the body unable to effectively fight off pathogens that would normally be harmless. With timely diagnosis and consistent adherence to antiretroviral therapy (ART), people living with HIV can prevent progression to AIDS and live long, healthy lives, often with a near-normal life expectancy. However, without treatment, AIDS is ultimately fatal, typically within a few years due to severe opportunistic infections or cancers. Unprotected sexual contact (vaginal, anal, oral) with an infected person.,Sharing contaminated needles or syringes (e.g., for intravenous drug use).,Perinatal transmission from mother to child during pregnancy, childbirth, or breastfeeding.,Receiving contaminated blood transfusions or organ transplants (rare in countries with robust screening).,Needle-stick injuries or exposure to infected blood in healthcare settings (occupational risk).
Sample MCQ
A patient diagnosed with Human Immunodeficiency Virus (HIV) exhibits progressive immunodeficiency, characterized by a significantly increased susceptibility to opportunistic infections. This heightened risk of infection is primarily due to a deficiency of which of the following:
- ACD8+ T lymphocytes
- BCD4+ T lymphocytes
- CB lymphocytes
- DNatural killer (NK) cells
Correct Answer: CD4+ T lymphocytes
### TLDR HIV primarily targets and destroys **CD4+ T lymphocytes**, which are central orchestrators of the adaptive immune response. This progressive depletion cripples cell-mediated immunity, leading to profound immunodeficiency and a significantly increased susceptibility to opportunistic infections characteristic of AIDS. ### Comparison Table | Option | Mechanism | Clinical Nuance | Key Distinction | |---|---|---|---| | CD8+ T lymphocytes | Kill virus-infected cells. | Important for viral control. | Not primarily depleted by HIV. | | **CD4+ T lymphocytes** | Coordinate immune responses. | Depletion causes immunodeficiency. | **Main HIV target; progressive loss.** | | B lymphocytes | Produce antibodies. | Antibody production can be impaired. | Not directly targeted or destroyed. | | Natural killer (NK) cells | Kill infected/tumor cells. | Crucial for early viral defense. | Not primary cause of profound immunodeficiency. | ### Detailed Breakdown The correct answer is **CD4+ T lymphocytes**. **CD4+ T lymphocytes**, also known as helper T cells, are paramount orchestrators of the adaptive immune system. They recognize antigens presented by antigen-presenting cells and then activate other crucial immune cells, including B lymphocytes (to produce antibodies) and cytotoxic CD8+ T lymphocytes (to kill infected cells). HIV specifically targets and infects **CD4+ T lymphocytes** by binding to the CD4 receptor and co-receptors (CCR5 or CXCR4) on their surface. Once infected, these cells are progressively destroyed, either directly by viral replication, by cytotoxic T cells recognizing viral antigens, or through programmed cell death (apoptosis). The relentless and progressive destruction of **CD4+ T lymphocytes** is the hallmark of HIV infection. As their count drops below critical thresholds (e.g., typically below 200 cells/µL), the immune system's ability to mount effective responses against various pathogens is severely compromised. This profound immunodeficiency primarily affects cell-mediated immunity, leaving the body highly susceptible to opportunistic infections, which are typically controlled by a healthy immune system. Examples include *Pneumocystis jirovecii* pneumonia, *Toxoplasma gondii* encephalitis, and *Mycobacterium avium* complex infections. While other immune cells are involved in HIV pathogenesis and their functions can be altered: * **CD8+ T lymphocytes** (cytotoxic T cells) are crucial for killing virus-infected cells, including HIV-infected cells, and are part of the host's defense. HIV does not primarily deplete them; rather, their function might be impaired due to the lack of help from **CD4+ T lymphocytes**. * **B lymphocytes** produce antibodies. While some B cell dysfunction and hypergammaglobulinemia can occur in advanced HIV, they are not directly targeted and destroyed by HIV, nor is their deficiency the primary cause of the broad range of opportunistic infections characteristic of AIDS. * **Natural killer (NK) cells** are part of the innate immune system, providing early defense against viral infections and tumors. While their function can be altered in HIV, their deficiency is not the fundamental cause of the progressive immunodeficiency and susceptibility to the specific opportunistic infections seen in AIDS, which largely stems from a failure of adaptive immunity spearheaded by **CD4+ T lymphocytes**.
Related Clinical Topics
Bradycardia
Bradycardia is a medical condition characterized by a slower than normal heart rate, typically defined as fewer than 60 beats per minute (bpm) in adults. While sometimes physiological and benign, it can also indicate underlying cardiovascular or systemic issues that impair the heart's ability to effectively pump blood. Treatment for bradycardia depends on its underlying cause, severity, and the presence of symptoms. Asymptomatic bradycardia, especially in athletes, often requires no intervention. Symptomatic bradycardia may necessitate discontinuing or adjusting causative medications, treating underlying conditions, or in severe cases, implanting a permanent pacemaker to regulate heart rhythm. Acute, unstable bradycardia may require intravenous atropine or temporary pacing. Clinical manifestations range from asymptomatic presentation to severe symptoms depending on the degree of bradycardia and the patient's cardiovascular reserve. Common symptoms include fatigue, dizziness, lightheadedness, syncope (fainting), shortness of breath, and chest pain. In critical cases, it can lead to confusion, hypotension, and signs of organ hypoperfusion.
Chronic Hepatitis C Virus infection
Chronic Hepatitis C Virus (HCV) infection is a persistent inflammatory condition of the liver caused by the hepatitis C virus, defined by the presence of detectable HCV RNA for at least six months. This long-term infection can progressively lead to significant liver damage, including fibrosis, cirrhosis, and hepatocellular carcinoma. Current treatment primarily involves direct-acting antiviral (DAA) medications, which are highly effective oral regimens targeting specific viral proteins to inhibit HCV replication. These therapies typically achieve a sustained virologic response (SVR) in over 95% of patients, effectively curing the infection. Treatment duration usually ranges from 8 to 12 weeks, depending on the specific regimen and patient factors. Chronic HCV infection is often asymptomatic for many years, leading to a silent progression of liver disease. When symptoms do appear, they are often non-specific, such as fatigue, malaise, nausea, and right upper quadrant discomfort. As the disease advances to cirrhosis, signs of liver decompensation may emerge, including jaundice, ascites, peripheral edema, spider angiomata, and hepatic encephalopathy.
Chronic hypertension
Chronic hypertension is a persistent and sustained elevation of blood pressure, typically defined as a systolic blood pressure greater than or equal to 130 mmHg or a diastolic blood pressure greater than or equal to 80 mmHg on multiple occasions. It is a major modifiable risk factor for various cardiovascular diseases, stroke, and kidney disease. Treatment for chronic hypertension involves a multi-faceted approach, starting with lifestyle modifications such as dietary changes (e.g., DASH diet), regular physical activity, weight loss, and reduced sodium and alcohol intake. Pharmacological therapy is often necessary and may include various classes of antihypertensive medications like diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and calcium channel blockers, frequently used in combination to achieve target blood pressure. Chronic hypertension is often referred to as 'the silent killer' because it is frequently asymptomatic for many years, even at high levels. When symptoms do occur, they are typically non-specific and may include headaches, dizziness, nosebleeds, or shortness of breath, usually manifesting in severe or long-standing cases or during a hypertensive crisis. Most diagnoses are made during routine medical screenings.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks